Zenabis receives final license amendment for Zenabis Atholville site


Zenabis Global (TSX:ZENA) has received the licensing of Phase 2C – Part 2 at its Zenabis Atholville site in New Brunswick for an additional 3,000 kg of licensed annual cultivation capacity of cannabis.

The amendment increases Zenabis’ total licensed annual cultivation capacity to 57,000 kg of dried cannabis from 54,000 kg, and Zenabis Atholville licensed annual cultivation capacity to 46,300 kg from 43,300 kg of dried cannabis.

The amendment also increases licensed operating space at Zenabis Atholville to 380,000 square feet from the existing 295,200 square feet.

In a statement, Andrew Grieve, CEO, said the receipt of the Phase 2C – Part 2 license amendment is the final key license amendment for Zenabis Atholville. “In nine months, we have increased the licensed annual cultivation capacity of Zenabis Atholville from less than 6,000 kg to 46,300 kg of dried cannabis.”

Mr. Grieve said the project came in substantially on time and under budget. “Our Zenabis Atholville licensing and construction teams are currently focused on completing the Zenabis Langley Site A – Phase 2 conversion.”

Sign up for the BioTuesdays weekly newsletter

Get the latest news on the healthcare industry’s corporate and clinical developments, executive moves, and market updates. Every Tuesday, in your inbox.